课题基金 / 基金详情

The importance of connexin 43 and its phosphorylation for mitochondrial function and myocardial ischemia/reperfusion injury

The importance of connexin 43 and its phosphorylation for mitochondrial function and myocardial ischemia/reperfusion injury
连接蛋白43及其磷酸化对线粒体功能和心肌缺血/再灌注损伤的重要性
批准号:
411490269
负责人:
Privatdozentin Dr. Kerstin Böngler
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2021-12-31

项目摘要

项目成果

Privatdozentin Dr. Kerstin Böngler的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Connexin 43 (Cx43) is localized at gap junctions of the cardiomyocyte sarcolemma, but is also present at the inner membrane of subsarcolemmal mitochondria. Here, the protein is involved in dye uptake and potassium influx, suggesting that Cx43 also forms a channel at the mitochondria. Furthermore, mitochondrial Cx43 influences oxygen consumption and calcium handling. A reduction in mitochondrial Cx43 is associated with a loss of cardioprotection following ischemic preconditioning (IPC). Gap junctional Cx43 is phosphorylated at multiple sites by different kinases, and also mitochondrial Cx43 is phosphorylated. The exact residues, which are phosphorylated in mitochondrial Cx43 under physiological conditions, after ischemia/reperfusion without and with IPC are unknown and will be identified using phospho-specific antibodies. Cx43 phosphorylation will be studied in wildtype mice as well as in mice, in which specific phosphorylation sites within Cx43 (targeted by protein kinase C (Cx43PKCmut mice), casein kinase 1 (Cx43CK1mut mice), and mitogen-activated protein kinase (Cx43MK4mut mice)), are rendered phosphorylation-insensitive. We aim to identify proteins which interact with mitochondrial Cx43. Mitochondrial function will be analyzed in mitochondria from Cx43PKCmut, Cx43CK1mut und Cx43MK4mut mice, and will be compared to that of wildtype mice. The importance of Cx43 phosphorylation will be studied by subjecting wildtype and Cx43 phosphorylation-insensitive mice to myocardial ischemia/reperfusion without or with ischemic preconditioning and myocardial infarct size will be quantified.Prior data on the importance of Cx43 for mitochondrial function and ischemia/reperfusion injury were obtained in models with genetic reduction or pharmacological inhibition of Cx43. To evaluate the effect of enhanced amounts of Cx43, we generated mice, in which the expression of Cx43 can be induced in cardiomyocytes by the administration of tamoxifen. The amount of gap junctional and mitochondrial Cx43 will be analyzed in these mice and compared to that of wildtype mice. The importance of Cx43 for heart function will be characterized by echocardiography. In addition, mitochondrial function will be studied in Cx43-overexpressing mice. In mitochondria from aged myocardium, the amount of mitochondrial Cx43 is reduced. This Cx43 reduction is associated with a loss of infarct size reduction by ischemic preconditioning. In a rescue experiment, Cx43 overexpression will be induced in aged mice and infarct size will be determined after ischemia/reperfusion without and with ischemic preconditioning.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bedeutung von p66Shc bei der Kardioprotektion durch ischämische Prä- und Postkonditionierung
  • 批准号:
    198215150
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2011
  • 负责人:
    Privatdozentin Dr. Kerstin Böngler
  • 依托单位:
Stat3: its role in cardiomyocyte mitochondria and in the cardioprotection by ischemic postconditioning
  • 批准号:
    66045107
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Privatdozentin Dr. Kerstin Böngler
  • 依托单位:
国内基金
海外基金
星形胶质细胞AMFR泛素化Connexin-43抑制“乳酸穿梭”途径参与帕金森病多巴胺能神经元死亡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
  • 依托单位:
抗抑郁新靶点Connexin43介导星形胶质细胞的胶质传递及知母宁的干预机制
  • 批准号:
    82274127
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    张毅
  • 依托单位:
室管膜细胞Connexin43缺陷导致脑脊液Ca2+稳态异常影响觉醒调节的机制研究
Connexin43介导的星形胶质细胞表型转化在肺癌脑转移中的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    周东
  • 依托单位: